Skip to main content

ADVERTISEMENT

Riccardo Lencioni, MD

Clinical Insights
11/11/2015
Interventional locoregional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided percutaneous ablation is recommended in patients with early-stage HCC when surgical options are precluded and can replace...
Interventional locoregional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided percutaneous ablation is recommended in patients with early-stage HCC when surgical options are precluded and can replace...
Interventional locoregional...
11/11/2015
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology